Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Disaccharidases are a group of essential hydrolase enzymes located on the brush border membrane of the small intestinal enterocytes [UniProt, https://www.uniprot.org/uniprotkb/P14410/entry]. They catalyze the final step of carbohydrate digestion by breaking down disaccharides, such as sucrose, maltose, and lactose, into monosaccharides like glucose and fructose for systemic absorption [NIH, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945292/]. Key enzymes in this class include sucrase-isomaltase, maltase-glucoamylase, and lactase. In therapeutic contexts, these enzymes are the primary targets for alpha-glucosidase inhibitors like acarbose and miglitol, which are used to manage postprandial hyperglycemia in type 2 diabetes mellitus [StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK557848/]. By inhibiting these enzymes, the rate of glucose entry into the bloodstream is reduced, helping to stabilize blood sugar levels. Conversely, deficiencies in these enzymes lead to clinical malabsorption syndromes characterized by osmotic diarrhea and bloating due to the fermentation of undigested sugars by colonic bacteria [PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Acarbose].
Competitive inhibition of intestinal alpha-glucosidases and disaccharidases, which delays the hydrolysis of dietary oligosaccharides and disaccharides into monosaccharides, thereby slowing glucose absorption.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Disaccharidase.